Company Search:
Advanced Search
Sponsored Links
ArQule, Inc. Company Snapshot
ArQule, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares ArQule with three other companies in this sector in the United States: Fortress Biotech Inc (2018 sales of $26.88 million of which 87% was Dermatology Product), CTI BioPharma Corp ($26.29 million of which 100% was License & Contract Revenues), and Quotient Ltd ($24.73 million of which 100% was Pharmaceutical Preparation).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ArQule, Inc.
  Stock Performance Chart for ArQule, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 8.58
(Figures in U.S. Dollars)
1 Week 3.5%   13 Weeks 7.7%  
4 Weeks -22.4%   52 Weeks 94.1%  
ArQule, Inc. Key Data:
  Ticker: ARQL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 25,764,000
(Year Ending Jan 2019).
Employees: 36
  Currency: U.S. Dollars Market Cap: 1,031,834,103
  Fiscal Yr Ends: December Shares Outstanding: 120,260,385
  Share Type: Common Closely Held Shares: 1,943,490
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.